About Us
Hemolab MD was established in 1994 to meet the needs of nephrologists.
Hemolab MD distributes and markets innovative medical devices.
Hemolab MD is a leader in renal failure treatments and has expanded into other therapeutic areas.
Hemolab MD continues to grow by investing in technologies with significant medical benefits.
Mission
To contribute to saving and sustaining lives through innovative and robust technologies.
Vision
To be an essential, competent, and recognized local and regional player.
Values
ENTREPRENEURSHIP
Innovate with agility, commitment, and ownership
PERSEVERANCE
Relentlessly pursue our efforts
HUMILITY
Achieve collectively with merit and without pretension
INTEGRITY
Operate with clarity, transparency and integrity
RESPECT
Treat everyone with professionalism and respect
TEAM
Be united, proactive, and reliable
History
Hemolab is a pioneer in hemodialysis in Morocco established in 1994. It diversified its activities in 1995 with Hemolab Pharma, becoming the first manufacturer of hemodialysis concentrate in the country. The acquisition of SPMCP in 2000 strengthened its position in the medical devices segment. Since then, the group has expanded to cover anaesthesia, resuscitation, oncology, biopharmaceuticals, diagnostics and water.
Activities
Hemodialysis and Hemodiafiltration Generator

Robust and innovative hemodialysis and hemodiafiltration generators that simplify, automate, and secure treatments to prioritize patients.
Advanced features include the measurement of recirculation, blood volume, and purification.
Artificial Kidneys

Every patient is unique. Hemolab MD offers two ranges of low and high flux dialyzers suitable for all types of treatments (HD, HDF).
This allows the nephrologist to tailor their prescription for quality treatment.
Continuous Renal Replacement Therapies

A complete range of medical devices, medications, and a machine specifically designed for Continuous Renal Replacement Therapies. in emergency and intensive care units.
Hemolab MD provides innovative, ergonomic, and robust technology along with support and training for your teams to master and independently administer prescribed therapies.
Hemodialysis Concentrate

Leading manufacturer of hemodialysis concentrate in Morocco through Hemolab Pharma. We supply liquid concentrate in 5-litre and 10-litre containers, 1000-litre acid tanks, and 650-gram bicarbonate cartridges. We also install our centralized distribution system for the acid concentrate. Our medications dedicated to hemodialysis are manufactured in compliance with international standards.
We also have a complete range of medications for patients with nephrological conditions.
Medical Water Treatment

Hemolab MD assists you in defining your medical water treatment project through all phases: study, pre-treatment and water treatment design, installation, commissioning, maintenance, and upkeep.
HEMOLAB MD provides advice and offers robust, high-performance medical devices to ensure optimal water quality compliant with regulations.
Medications Dedicated to Hemodialysis

Hemolab offers a complete range of medications for patients with nephrological conditions (anticoagulants, injectable iron etc.)
Vascular Access

Catheters, needles, and arteriovenous lines designed to be user-friendly while ensuring patient safety and comfort.
Ophthalmology

A range of high-tech medical devices for cataract surgery:
- Preloaded HOYA implants for secure, simple insertion and unprecedented optical quality
- Precise and robust SURGISTAR knives
- Optimal ALBOMED viscoelastics for efficient surgery
Project Study Services

With over 30 years of experience and a comprehensive range, Hemolab MD can advise and offer the most suitable solution for your hemodialysis center:
- Hemodialysis center design
- Equipment requirement sizing
- Financing solutions
News
Partnership
Our partnerships have lasted for several decades, characterized by success resulting from strong synergies in terms of portfolio and channel.
These collaborations are meticulously studied, pre-planned, and executed methodically.
Our partners
References


